Primary Androgen Deprivation Therapy for Nonmetastatic Prostate Cancer in Asia: Unique or Not?

Restricted access
  • 1.

    Lu-Yao GL, Albertsen PC, Moore DF, . Fifteen-year survival outcomes following primary androgen-deprivation therapy for localized prostate cancer. JAMA Intern Med 2014;174:1460–1467.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2.

    Potosky AL, Haque R, Cassidy-Bushrow AE, . Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer. J Clin Oncol 2014;32:1324–1330.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 3.

    Studer UE, Whelan P, Wimpissinger F, . Differences in time to disease progression do not predict for cancer-specific survival in patients receiving immediate or deferred androgen-deprivation therapy for prostate cancer: final results of EORTC randomized trial 30891 with 12 years of follow-up. Eur Urol 2014;66:829–838.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4.

    Bill-Axelson A, Holmberg L, Garmo H, . Radical prostatectomy or watchful waiting in early prostate cancer. N Engl J Med 2014;370:932–942.

  • 5.

    Warde P, Mason M, Ding K, . Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet 2011;378:2104–2111.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6.

    Mohler JL, Antonarakis ES, Armstrong AJ, . NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer. Version 1.2019. Accessed March 12, 2019. To view the most recent version of these guidelines, visit NCCN.org.

  • 7.

    Bernard B, Muralidhar V, Chen YH, . Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancer. Cancer 2017;123:1536–1544.

  • 8.

    Akaza H, Umbas R, Ha Chung B, . NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) – Asia Consensus Statement: Prostate Cancer. Version 2.2013. Available at NCCN.org. Accessed March 12, 2019.

  • 9.

    Akaza H, Homma Y, Usami M, . Efficacy of primary hormone therapy for localized or locally advanced prostate cancer: results of a 10-year follow-up. BJU Int 2006;98:573–579.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10.

    Ha US, Choi JB, Shim JI, . Is primary androgen deprivation therapy a suitable option for Asian patients with prostate cancer compared with radical prostatectomy? J Natl Compr Canc Netw 2019;17:441–449.

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 639 639 15
PDF Downloads 136 136 0
EPUB Downloads 0 0 0